---
title: Improve walking speed and balance
nct_id: NCT07378722
phase: NA
status: RECRUITING
sponsor: Rumesa Butt
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07378722"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07378722"
last_fetched: "2026-05-10T14:02:00.216Z"
source: "Parkinson's Pathways (curated)"
---
# Improve walking speed and balance

**Goal (in five words):** Improve walking speed and balance

**Official Title:** Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease

**Trial ID:** [NCT07378722](https://clinicaltrials.gov/study/NCT07378722)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Rumesa Butt
- **Target Enrollment:** 50 participants
- **Start Date:** 2026-02-05
- **Completion Date:** 2026-04-05
- **Conditions:** Parkinson s Disease
- **Interventions:** conventional physical therapy, Rhythmic Auditory Stimulation (RAS)
- **Intervention Types:** BEHAVIORAL

## Summary For Families

Aiming to make walking and balance steadier in people with Parkinson's, this trial tests whether using personalized music beats can improve step timing, stride regularity, and overall gait control. Participants receive conventional physical therapy with Rhythmic Auditory Stimulation, where music with a tailored steady beat cues each step to engage auditory‑motor pathways and entrain movement timing, a non-drug approach that can complement existing medications. The study is enrolling adults 45 to 55 years old with a clinical Parkinson's diagnosis per Queen Square Brain Bank, MMSE over 23, mild balance impairment (BBS 21,40), and no serious medical, sensory, musculoskeletal, or recent neurologic music therapy history.

## Eligibility

- **Minimum age:** 45 Years
- **Maximum age:** 55 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* According to the Queen Square Brain Bank standard , clinical diagnosed patients of PD Both male and females ages 45-55 The mini mental state examination scale MMSE screening without severe cognitive impairment,can cooperate with this study \> 23 Mild bergs balance scale BBS score (21-40 ) score

Exclusion Criteria:

* A history of neoplasms; severe cardiovascular, respiratory, visual, auditory, andmuscular-skeletal disease; other neurological conditions; and neurologic music therapy inthelast3 months.

Other disorders that could potentially influence balance and walking.
```

## Locations (1)

- Shadman Medical Center, Lahore, Punjab Province, Pakistan _(31.5580, 74.3507)_
  - Rumesa Butt, MSPT N — (CONTACT) — 03044020918 — rumesaaslam5@gmail.com
  - Montiha Azeem, MSPTN — (CONTACT) — 03479717317 — muntahaazeem9@gmail.com
  - Rumesa Aslam, MSPTN — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Rumesa Butt, MSPTN — (CONTACT) — 03044020918 — rumesaaslam5@gmail.com
- Montiha Azeem, MSPTN — (CONTACT) — 03479717317 — muntahaazeem9@gmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT07378722*  
*HTML version: https://parkinsonspathways.com/trial/NCT07378722*  
*Source data: https://clinicaltrials.gov/study/NCT07378722*